Tricomin Hair Loss Products deliver the benefits of years of research and development by ProCyte Corporation, a leader in the art and science of healthy hair. Tricomin is a purported non-drug alternative to prevent hair loss, with copper as a key ingredient. The product is manufactured by the ProCyte corporation. Tricomin is a superoxide dismutase formed from a metal complexed peptide. This works as a hair growth stimulant by improving collagen synthesis and possibly repairing skin and hair function. An 80% response rate has been reported for Tricomin in early tests. This product was initially intended to be released as a hair-growth compound. The early-stage Phase II clinical study of the product had very positive results on some of the 36 male subjects who, applied the treatment topically twice a day for 24 weeks. Designed for men and women with thinning hair, Follicle Therapy Spray combines the benefits of clinically-tested Triamino Copper Nutritional Complex with an exceptional leave-in conditioner formulation. Tricomin solution enriches your hair and scalp with a unique blend of essential amino acids, minerals and body-building ingredients. Condition and treat your hair and scalp daily by spraying liberally after shampooing. May be applied to damp or dry hair.
Tricomin Ingredients:
Purified Water, SD Alcohol 40B, Amodimethicone, Nonoxynol-10, Panthenol, Polyquaternium-11, Polysorbate 60, Tallowtrimonium Chloride, Citric Acid, Dimethyl Lauramine Isostearate, Linoleamidopropyl Ethyl Dimonium Ethosulfate, Triamino Copper Nutritional Complex (Alanine/Histidine/Lysine Polypetide Copper HCl), Methylparaben, Benzethonium Chloride, Menthol, FD&C Blue #1. Tricomin's Triamino Copper Nutritional Complex allows the vital, yet often neglected, nutrient copper to be applied directly to the hair follicles so it can have a positive effect on hair growth. Tricomin uses powerful copper peptides to promote the healthiest hair follicles. This effect can stop or reverse hair loss.
Posted by
Hanjou
at
11:56 PM
Subscribe to:
Post Comments (Atom)

0 comments:
Post a Comment